These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30209680)

  • 1. pH-Promoted Release of a Novel Anti-Tumour Peptide by "Stealth" Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells.
    Sacchetti F; Marverti G; D'Arca D; Severi L; Maretti E; Iannuccelli V; Pacifico S; Ponterini G; Costi MP; Leo E
    Pharm Res; 2018 Sep; 35(11):206. PubMed ID: 30209680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells.
    Marverti G; Gozzi G; Maretti E; Lauriola A; Severi L; Sacchetti F; Losi L; Pacifico S; Ferrari S; Ponterini G; Leo E; Costi MP; D'Arca D
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32585842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conveying a newly designed hydrophilic anti-human thymidylate synthase peptide to cisplatin resistant cancer cells: are pH-sensitive liposomes more effective than conventional ones?
    Sacchetti F; D'Arca D; Genovese F; Pacifico S; Maretti E; Hanuskova M; Iannuccelli V; Costi MP; Leo E
    Drug Dev Ind Pharm; 2017 Mar; 43(3):465-473. PubMed ID: 27885848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Polyethylene Glycol Size in Chemical Spectra, Cytotoxicity, and Release of PEGylated Nanoliposomal Cisplatin.
    Shirzad M; Jamehbozorgi S; Akbarzadeh I; Aghabozorg HR; Amini A
    Assay Drug Dev Technol; 2019 Jul; 17(5):231-239. PubMed ID: 31081680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
    Shaji J; Menon I
    Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RGD-modified pH-sensitive liposomes for docetaxel tumor targeting.
    Chang M; Lu S; Zhang F; Zuo T; Guan Y; Wei T; Shao W; Lin G
    Colloids Surf B Biointerfaces; 2015 May; 129():175-82. PubMed ID: 25851582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced pH-Responsiveness, Cellular Trafficking, Cytotoxicity and Long-circulation of PEGylated Liposomes with Post-insertion Technique Using Gemcitabine as a Model Drug.
    Xu H; Paxton JW; Wu Z
    Pharm Res; 2015 Jul; 32(7):2428-38. PubMed ID: 25663325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro.
    Krieger ML; Eckstein N; Schneider V; Koch M; Royer HD; Jaehde U; Bendas G
    Int J Pharm; 2010 Apr; 389(1-2):10-7. PubMed ID: 20060458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cationic versus anionic core-shell nanogels for transport of cisplatin to lung cancer cells.
    Gonzalez-Urias A; Zapata-Gonzalez I; Licea-Claverie A; Licea-Navarro AF; Bernaldez-Sarabia J; Cervantes-Luevano K
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110365. PubMed ID: 31344612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-Sensitive PEGylated liposomes functionalized with a fibronectin-mimetic peptide show enhanced intracellular delivery to colon cancer cell.
    Garg A; Kokkoli E
    Curr Pharm Biotechnol; 2011 Aug; 12(8):1135-43. PubMed ID: 21470144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel doxorubicin loaded PEGylated cuprous telluride nanocrystals for combined photothermal-chemo cancer treatment.
    Wang X; Ma Y; Chen H; Wu X; Qian H; Yang X; Zha Z
    Colloids Surf B Biointerfaces; 2017 Apr; 152():449-458. PubMed ID: 28187379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin.
    Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J
    Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functionalization of carboxylated lignin nanoparticles for targeted and pH-responsive delivery of anticancer drugs.
    Figueiredo P; Ferro C; Kemell M; Liu Z; Kiriazis A; Lintinen K; Florindo HF; Yli-Kauhaluoma J; Hirvonen J; Kostiainen MA; Santos HA
    Nanomedicine (Lond); 2017 Nov; 12(21):2581-2596. PubMed ID: 28960138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macroporous silica nanoparticles for delivering Bcl2-function converting peptide to treat multidrug resistant-cancer cells.
    Xu W; Ge P; Niu B; Zhang X; Liu J; Xie J
    J Colloid Interface Sci; 2018 Oct; 527():141-150. PubMed ID: 29787950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery.
    Tam YT; To KK; Chow AH
    Colloids Surf B Biointerfaces; 2016 Mar; 139():249-58. PubMed ID: 26724466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NGR-modified pH-sensitive liposomes for controlled release and tumor target delivery of docetaxel.
    Gu Z; Chang M; Fan Y; Shi Y; Lin G
    Colloids Surf B Biointerfaces; 2017 Dec; 160():395-405. PubMed ID: 28965079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivering anti-cancer drugs with endosomal pH-sensitive anti-cancer liposomes.
    Moku G; Gulla SK; Nimmu NV; Khalid S; Chaudhuri A
    Biomater Sci; 2016 Apr; 4(4):627-38. PubMed ID: 26806172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-temperature dual-sensitive nucleolipid-containing stealth liposomes anchored with PEGylated AuNPs for triggering delivery of doxorubicin.
    García MC; Calderón-Montaño JM; Rueda M; Longhi M; Rabasco AM; López-Lázaro M; Prieto-Dapena F; González-Rodríguez ML
    Int J Pharm; 2022 May; 619():121691. PubMed ID: 35331830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer.
    Patel K; Doddapaneni R; Sekar V; Chowdhury N; Singh M
    Mol Pharm; 2016 Jun; 13(6):2049-58. PubMed ID: 27070720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatoma-targeting and pH-sensitive nanocarriers based on a novel D-galactopyranose copolymer for efficient drug delivery.
    Ding Y; Han J; Tian B; Han J; Zhang J; Zheng H; Han Y; Pei M
    Int J Pharm; 2014 Dec; 477(1-2):187-96. PubMed ID: 25455771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.